Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial
The Lancet, ISSN: 0140-6736, Vol: 385, Issue: 9978, Page: 1634-1641
2015
- 148Citations
- 183Captures
- 2Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations148
- Citation Indexes142
- 142
- CrossRef89
- Policy Citations4
- Policy Citation4
- Clinical Citations2
- PubMed Guidelines2
- Captures183
- Readers183
- 183
- Mentions2
- Blog Mentions1
- Blog1
- News Mentions1
- News1
Most Recent Blog
Richard Lehman’s journal review—26 January 2015
NEJM 22 Jan 2015 Vol 372 331 “Approximately one in four extremely premature infants born at 22 to 28 weeks of gestation does not survive the birth hospitalization; mortality rates decrease with each additional week of completed gestation.” I am not your best guide to this topic, but for those who want to know more, a new study maps trends in the survival of these babies in the USA. The data span
Most Recent News
A Multicenter Study to Evaluate the ROX Coupler in Subjects With Hypertension; CONTROL HTN-2
STUDY INFORMATION OFFICIAL TITLE: A Prospective, Randomized, Adaptive, Double-Blind, Sham-Controlled, Multicenter Study to Evaluate the ROX Coupler in Subjects With Hypertension CURRENT STATUS: Recruiting STUDY
Article Description
Hypertension contributes to cardiovascular morbidity and mortality. We assessed the safety and efficacy of a central iliac arteriovenous anastomosis to alter the mechanical arterial properties and reduce blood pressure in patients with uncontrolled hypertension.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0140673614620535; http://ClinicalTrials.gov; http://dx.doi.org/10.1016/s0140-6736(14)62053-5; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84933279414&origin=inward; https://clinicaltrials.gov/ct2/show/NCT01642498; http://www.ncbi.nlm.nih.gov/pubmed/25620016; https://linkinghub.elsevier.com/retrieve/pii/S0140673614620535; http://linkinghub.elsevier.com/retrieve/pii/S0140673614620535; http://api.elsevier.com/content/article/PII:S0140673614620535?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0140673614620535?httpAccept=text/plain; https://facultyopinions.com/prime/725326211#eval793511344; http://dx.doi.org/10.3410/f.725326211.793511344; http://dx.doi.org/10.1016/S0140-6736%2814%2962053-5; http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)62053-5/abstract; http://www.thelancet.com/article/S0140673614620535/pdf; http://www.thelancet.com/article/S0140673614620535/abstract; http://www.thelancet.com/article/S0140673614620535/fulltext; http://www.thelancet.com/retrieve/pii/S0140673614620535; http://f1000.com/prime/725326211#eval793511344; http://europepmc.org/abstract/med/25620016
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know